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self-renewal, survival, and duration of
emigration in a highly context-dependent
manner in the dorsal neural tube.
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The neural crest is a transient embryonic population
that originates within the central nervous system
(CNS) and then migrates into the periphery and dif-
ferentiates into multiple cell types. The mechanisms
that govern neural crest stem-like characteristics
and self-renewal ability are poorly understood.
Here, we show that the proto-oncogene cMyc is a
critical factor in the chick dorsal neural tube, where
it regulates the size of the premigratory neural crest
stem cell pool. Loss of cMyc dramatically decreases
the number of emigrating neural crest cells due to
reduced self-renewal capacity, increased cell death,
and shorter duration of the emigration process. Inter-
estingly, rather than via E-Box binding, cMyc acts in
the dorsal neural tube by interacting with another
transcription factor, Miz1, to promote self-renewal.
The finding that cMyc operates in a non-canonical
manner in the premigratory neural crest highlights
the importance of examining its role at specific time
points and in an in vivo context.
INTRODUCTION
Neural crest cells are multipotent cells that give rise to tens of
different cell types in vertebrate embryos, ranging from craniofa-
cial cartilage and bone to peripheral ganglia and melanocytes of
the skin (Dupin and Coelho-Aguiar, 2013). Premigratory neural
crest cells start as neuroepithelial cells in the dorsal neural
tube that subsequently undergo an epithelial-to-mesenchymal
transition (EMT), migrating from their site of origin in the CNS
to diverse destinations within the developing embryo (Kerosuo
and Bronner-Fraser, 2012). The premigratory phase lasts about
24 hr in the bird embryo. Due to its transient nature, the process
of neural crest productionmust be tightly regulated. However, lit-
tle is known about what regulates the size of the neural crest
stem cell pool and/or whether it is comparable to other stem
cell niches. Therefore, despite the high clinical relevance and
need to understand how neural crest ‘‘stemness’’ is maintained,
the in vivo mechanisms that control the numbers of neural crest
precursors and duration of their emigration process are poorly
understood.2648 Cell Reports 17, 2648–2659, December 6, 2016 ª 2016 The Au
This is an open access article under the CC BY-NC-ND license (http://The transcription factor and proto-oncogene cMyc has been
implicated in a broad range of cellular functions (Eilers and Ei-
senman, 2008), including cell proliferation and apoptosis. It has
been estimated to regulate 15% of the genome and has an es-
tablished role in stem cell maintenance in both embryonic stem
cells and tissue-specific stem cell niches in adults and in the em-
bryo (Chappell and Dalton, 2013; Dong et al., 2011; Kerosuo
et al., 2008; Kwan et al., 2015; Varlakhanova et al., 2010; Wilson
et al., 2004). Myc is often dysregulated in cancer cells, corre-
lating with poor prognosis in many neural-crest-derived tumors
such as neuroblastoma (Fredlund et al., 2008) and melanoma
(Bosserhoff, 2006). In the chick, the Myc paralogs, cMyc and
nMyc, exhibit complementary expression patterns during neural
crest development, with nMyc expressed early in the neural plate
and its border and later in the middle and ventral neural tubes
(Khudyakov and Bronner-Fraser, 2009); in contrast, cMyc is ex-
pressed in premigratory neural crest cells within the dorsal neural
tube. In the frog, the expression of these paralogs is switched so
that cMyc is expressed early in the neural plate border, where it is
required for induction of neural crest fate; loss of cMyc reverts
cells to a neural fate without affecting proliferation or cell death
of the stem cell pool (Bellmeyer et al., 2003). In zebrafish,
hMyc, which is genetically closer to nMyc than to cMyc, is ex-
pressed in the neural plate during neural crest specification,
and its knockdown affects both neural induction and proper
development of neural-crest-derived tissues such as the pharyn-
geal arches (Hong et al., 2008). Similarly, conditional knockdown
of cMyc in mice using Wnt1-Cre results in defects in the forma-
tion of pigment, skull, and ear (Wei et al., 2007). Reprogramming
ofmurine radial glial cells withBrn2 and cMyc induces character-
istics of early neural crest cells (Bung et al., 2016). Finally, over-
expression of avian nMyc after EMT in migratory neural crest
cells results in the differentiation of neurons at the expense of
other neural-crest derivatives (Wakamatsu et al., 1997). How-
ever, the relative roles of nMyc and cMyc in the early neural crest
remain unclear.
Here, we tackle the role of the multifunctional protein cMyc
(Eilers and Eisenman, 2008) in the premigratory neural crest of
avian embryos. Initiation of cMyc expression begins concomi-
tant with the onset of EMT, consistent with its proposed role as
a late neural crest specifier gene (Sauka-Spengler and Bron-
ner-Fraser, 2008). Moreover, we find that cMyc plays a critical
role in regulating the size of the premigratory neural crest cell
pool by promoting self-renewal and survival. This role is different
from its canonical role in activating transcription together with itsthor(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Onset Of cMyc Expression in the
Premigratory Neural Crest
(A–D) In situ hybridization shows no cMyc
expression in the neural plate at gastrula stage (A)
or in the neural folds at Hamburger Hamilton (HH)
stage 7 (B). cMyc expression initiates in the pre-
migratory cranial neural crest within the dorsal
neural tube at Hamburger Hamilton (HH) stage 8
prior to EMT (C) and remains on during emigration
from the neural tube at stage 9 (D). cMyc expres-
sion overlaps with that of the neural crest marker
Pax7 in the dorsal neural tube, observed in a
transverse section by immunostaining. (C’)
(E, E’, and F) cMyc expression persists in neural
crest cells throughout migration.
Scale bars, 150 mm for whole embryos and 20 mm
for sections. See also Figure S1.binding partner Max via E-Box binding. Instead, our results show
that, in the premigratory neural crest, cMyc/Max function de-
pends upon interaction with another transcription factor, Miz-1,
to form a repressive complex. Our results suggest that the
Myc/Miz1 complex transcriptionally regulates levels of factors,
including cyclin-dependent kinase inhibitors, thus enabling
the cell-cycle progression required for self-renewal. Although
cMyc is well known for its ability to induce proliferation, this
does not appear to be the case in the neural crest, highlighting
its tissue-specific roles. These results provide insights into the
mechanisms that regulate self-renewal ability in the premigratory
neural crest stem cell pool.
RESULTS
Given the existence of notable species-specific differences in
the expression of cMyc in the early ectoderm, we performed a
careful analysis of the expression pattern in the chick embryo
by in situ hybridization (Figure 1; Figure S1). The results show
that, unlike in the frog (Bellmeyer et al., 2003), cMyc expression
is absent from the neural plate and neural plate border (Figures
1A and 1B; Figures S1A–S1D) but is first detected in the cranial
dorsal neural folds during neural tube closure at the five- to six-
somite stage (Hamburger Hamilton [HH] stage 8+; Figure 1C).
The expression overlaps with Pax7-immunopositive premigra-
tory neural crest cells (Figure 1C’). Intense cMyc expression
is maintained in neural crest cells throughout emigration and
migratory stages (HH stages 9–12; Figures 1E and 1F; Figures
S1E and S1F).
We next examined the effects of cMyc loss of function in the
neural crest by electroporating a translation-blockingmorpholino
onto one side of the embryo at gastrula stages. As an internal
control, a control morpholino was electroporated on the con-
tralateral side of the same embryo, which was analyzed the
following day (Figure 2A). 1.2 mM morpholino had no effect on
the induction of neural crest cells at the neural plate border prior
to the time of initiation of cMyc expression in the neural folds,Cell Reporwhich also demonstrates that the mor-
pholino treatment did not cause any
non-specific effects (Figures S2A–S2C).In contrast, at premigratory stages (HH8+/9), cMyc knockdown
reduced the numbers of FoxD3- and Pax7-expressing neural
crest cells compared to control embryos. As a result, the neural
crest cell domain in the tip of the dorsal neural tube was signifi-
cantly smaller on the cMyc-morphant side (Figures 2B–2D).
However, expression of the neural marker Sox2 was not
affected (Figure 2D). The same phenotype persisted throughout
the emigration and migration periods (Figures 2E–2H) with, on
average, 85% (for stages 8–10 combined) of the embryos, result-
ing in a decrease in size of the neural crest population on the
cMyc morpholino (cMycMO)-treated side compared with 10%
in control embryos (Figure 2G). Duringmigratory stages (stage 9),
this resulted in fewer Sox10-positive neural crest cells on the
cMycMO-treated side. In addition, emigration was delayed, so
that none of the cMycMO-electroporated cells had delaminated
at the time when the first neural crest cells on the control mor-
pholino side already were migrating (Figures 2E and 2F). As
emigration continued, neural crest cells migrated further laterally
on the control side, as viewed in whole mount. In contrast,
a Sox10-negative area was visible adjacent to the midline in
cMycMO-treated embryos. Transverse sections revealed that
emigration had ended on the cMycMO-treated side so that no
more neural crest cells were emerging from the dorsal neural
tube. In contrast, production of Sox10-positive cells was still
observed on the control side (Figures 2H–2Hhh). Higher dosage
of the cMycMO (1.5mM and up) resulted in an almost-complete
loss in expression of the neural crest markers FoxD3 and Sox10
and caused severe degradation of the dorsal neural tube (Figures
S2D–S2G). Because cMyc and nMyc have non-overlapping
patterns in the neural tube, we analyzed whether cMyc knock-
down caused a compensatory increase in nMyc levels in the
neural crest cells. However, no changes in nMyc expression
were observed after loss of cMyc (Figure S2H).
The apparent decrease in size of the neural crest cell pool
prompted us to test whether loss of cMyc affects the ability of
the cells to self-renew. To this end, we performed a colony-
forming assay using chick crestospheres that, as we previouslyts 17, 2648–2659, December 6, 2016 2649
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Figure 2. cMyc Regulates the Size of the
Neural Crest Stem Cell Pool
(A) Translation-blocking cMycMO was electro-
porated into gastrula-stage (HH stage 4) embryos
on one side, while the contralateral side was in-
jected with control morpholino as an internal
control and analyzed the next day.
(B and C) cMyc knockdown reduces the numbers
of premigratory neural crest cells in the dorsal
neural tube, as shown by in situ hybridization for
FoxD3 (B), whereas control embryos show similar
levels of FoxD3 expression on both sides (C).
(D) The size of the neural crest cell domain is
smaller, as shown by Pax7 immunostaining, but
Sox2 protein levels are similar on both sides (n = 9/
9 for Sox2/Pax7 immunostaining).
(E and F) In (E), at HH stage 9, fewer Sox10-posi-
tive neural crest cells (black arrow) are noted on
the cMyc-morphant side, and their emigration has
not yet started, whereas neural crest cells have
emigrated on the control side (blue arrow); in (F),
control embryos are similar on both sides.
(G) 85% of embryos have a reduced number
of neural crest cells and, thus, a smaller neural
crest stem cell pool on the cMyc-morphant side
compared with only 10% of control embryos
(n = 58 for stage 8–10 combined; n = 20 for control
embryos).
(H) The phenotype persists during the migration
phase: emigration starts later and ends sooner on
the cMyc-morphant side leaving a Sox10-negative
region next to the midline (magnified in h, and
marked by a black arrow in hh), whereas new
Sox10-positive cells are still produced in the dorsal
neural tube on the contralateral side (phenotype
seen in 83%of embryos; n = 30). Overall, this leads
to a smaller size of the neural crest cell pool as
visualized by the brackets with different length.
A green asterisk (or white, in A) marks the treated
side.
Scale bars, 20 mm. See also Figure S2.showed, could be kept in vitro as primary epithelial neural crest
stem cells (Kerosuo et al., 2015) and, thus, maintained high
expression levels of cMyc similar to that of premigratory neural
crest cells (Figures 3A and 3B). After cMyc knockdown was
achieved by using two different small interfering RNAs (siRNAs),
we found that the self-renewal capacity was reduced by half
(Figure 3C) after an 30%–40% decrease in cMyc expression
levels assayed by qPCR (Figure 3D). In addition, many of the
newly formed cMyc-deficient spheres were smaller in size
(15 cells per sphere as compared to30–50 cells, on average,
in untreated spheres). The capacity of secondary sphere
formation was also reduced after cMyc knockdown, further
demonstrating an effect on self-renewal rather than proliferation
(Figure 3E).
We also examined the differentiation capacity of cMycMO-
treated neural tube explants. After a week of in vitro differentia-
tion, we detected several types of neural crest derivatives similar
to those seen in control cultures (data not shown; n = 12
embryos), as indicated by staining of neurons with Tuj1, melano-
blasts with Mitf, smooth muscle cells with SMA, and glial cells
with BLBP antibody (Ab), respectively (Figures 3F and 3G).2650 Cell Reports 17, 2648–2659, December 6, 2016Since cMyc is known for its role in cell proliferation and survival
(Eilers and Eisenman, 2008), we examined whether cell prolifer-
ation and/or survival were affected after cMyc-MO knockdown.
The results show that the proliferation rate in the neural crest was
not changed in a statistically significant manner, though we did
detect a slight decrease in the numbers of proliferating cells
by using phospho-histone 3 staining (Figure 4A; Figure S3A).
Instead, we consistently detected fewer cells in the dorsal neural
tube (Figure 4B). The tip of the neural tube also appeared thinner
and improperly folded on the cMycMO-treated side (Figures 4D
and 4F). Since proliferation was not noticeably affected, and
higher cMycMO concentrations caused degradation of the dor-
sal neural tube (Figure S2), we next examined whether lack of
cMyc caused apoptosis in late stage 8 neural folds examined
by caspase-3 immunostaining. As compared to the control-
morpholino-injected side, cMycMO increased apoptosis 4-fold
(Figures 4C and 4E).
To gain insight into possible downstream effectors of cMyc,
we performed qPCR to examine changes in expression of known
cMyc targets associated with proliferation and cell survival (Fig-
ure 4G). Surprisingly, neither the cell-cycle activator CyclinE nor
Figure 3. cMyc Regulates Self-Renewal but Not Multipotency of Neural Crest Cells
(A and B) In (A), self-renewal was measured in vitro by using the colony-forming assay on crestospheres (B) that express high levels of cMycmRNA, as shown by
in situ hybridization.
(C) siRNA knockdown of cMyc significantly reduces neural crest cell self-renewal capacity (siRNA1: average = 0.41-fold, SEM = 0.076; n = 6; siRNA2: average =
0.54-fold, SEM = 0.13, n = 6; control-siRNA [co-siRNA] average = 1-fold, SEM = 0.152, n = 12; t test siRNA1/Co-IP = 0.00358; siRNA2/Co-IP = 0.0355).
(D) Reduced cMyc expression levels after siRNA knockdown (average for siRNA1 = 0.577, SEM = 0.121, n = 3; average for siRNA2 = 0.748, SEM = 0.022: n = 3).
(E) cMyc knockdown also reduces secondary sphere formation capacity (cMyc siRNA = 0.456208929, SEM = 0.092996221, n = 6; control siRNA = 1, SEM =
0.237695836, n = 6; p = 0.04310364).
(F and G) Differentiation of neural tube explants electroporated with cMycMO. cMyc-deficient neural crest cells were able to differentiate into all major types
of neural crest derivatives including melanoblasts (Mitf) and smooth muscle (SMA) cells (F), as well as neurons (TUJ1), and glial cells (BLBP) as a proof of
multipotency (G) (n = 24 embryos).
Scale bars, 50 mm.
Cell Reports 17, 2648–2659, December 6, 2016 2651
cMYCMo / CoMo
CoMo / CoMo
1.1
0.2
0.6
1.0
1.4
1.0 1.01.1
0.4 0.5
1.01.1
****nsns
*
0.9
1.4
cMYCMoCoMoCaspase 3
Dapi
Cy
cli
nE
BC
L2
FO
XD
3
SO
X1
0
p2
7
E F
D
* *
*
Stage 8
'!"
D’D’
PH3
Fo
ld
 c
ha
ng
e
1
0.6
0.2
ns
60
50
40
0
cell number
# 
nu
cl
ei
 in
 d
or
sa
l n
eu
ra
l t
ub
e
**
Fo
ld
 c
ha
ng
e
1
3
5p=0.09 **
Caspase 3
STAGE 8
dorsal neural tubes
Ex
pr
es
sio
n 
fo
ld
cMYCMo
CoMo
QPCR
STAGE 8-9
 neural tubes
A B C
G
*
P27
merge PH3
Caspase 3 Dapi
Q-PCR
ex
pr
es
sio
n 
le
ve
l r
el
at
ive
 to
 c
on
tro
l s
iR
NAH
J 
K I 
Fo
ld
 c
ha
ng
e
1
0.6
0.2
1.4
Fo
ld
 c
ha
ng
e
1
0.6
0.2
1.4
PH3
Caspase 3
cMYCsiRNA
CosiRNA
ns
ns
1
0.6
0.2
1.4
Figure 4. Neural Crest Cell Survival Requires cMyc
(A–F) In (A), cMyc deficiency does not affect proliferation in a statistically significant way (cMycMO average = 0.702, SEM= 0.12, n = 7 embryos; CoMo = 1, SEM=
0.105; n = 7 embryos), (B and D) although the dorsal neural tube has fewer cells on the Myc-deficient side (on average, 47 cells in the tip of the dorsal neural tube,
SEM = 1.499, as compared to 55 cells on the tips on the CoMo side, SEM = 1.51; n = 26 slides in six embryos; p = 0.00020924, t test), (C, E, and F) likely due to a
massive decrease in cell survival as shown by caspase-3 immunostaining (average = 4.13, cMycMo SEM = 0.2039, n = 6 embryos, and CoMo SEM = 0.1700912;
n = 6 embryos, p = 4.534E07, t test) and (D and D’) incorrect folding of the dorsal neural folds. ns, not significant.
(G) qPCRdata show no change in known targets of cMyc involved in cell proliferation (CyclinE: cMycMO/CoMo average = 0.997, SEM= 0.098, n = 8; CoMo/CoMo
average = 1.1, SEM= 0.22, n = 4; t test cMycMO/CoMo, p = 0.63) or survival (BCL2: cMycMO/CoMo average = 0.977, SEM= 0.082, n = 8; CoMo/CoMo average =
1.09, SEM = 0.26, n = 4; t test cMycMO/CoMo, p = 0.62), even though neural crest genes (FoxD3 and Sox10) are downregulated (FoxD3 cMycMO/CoMo
average = 0.41, SEM = 0.07, n = 6; Sox10 cMycMO/CoMo average = 0.50, SEM = 0.08, n = 6; FoxD3 CoMo/CoMo average = 1.13, SEM = 0.13, n = 7; Sox10
CoMo/CoMo average = 1.03, SEM = 0.06, n = 7; t test cMycMO/CoMo FoxD3, p = 0.00111, and Sox10 p = 0.00036). Instead, the CDKI p27 is increased in cMyc
morphants (cMycMO/CoMo average = 1.39, SEM = 0.148, n = 7; CoMo/CoMo average = 0.93, SEM = 0.082, n = 4; p = 0.0215, t test). This suggests an alternative
mechanism for cMyc function other than E-Box binding.
(H) Immunostaining for proliferation (PH3) and apoptosis (caspase-3) in crestospheres transfected with cMyc siRNA.
(I) Knockdown of cMyc does not alter proliferation in crestospheres (PH3 cMyc siRNA average = 1.13, SEM = 0.17, n = 10; Co-siRNA = 1, SEM = 0.17; p = 0.672,
t test.
(J) Cell survival was not affected by cMyc siRNA knockdown in crestospheres caspase-3 (cMyc siRNA average = 1.05, SEM = 0.11, n = 10; control = 1,
SEM = 0.23, n = 7, p = 0.68, t test).
(K) Knockdown of cMyc increses p27 mRNA levels in crestospheres (cMyc siRNA average = 1.21; SEM = 0.06; n = 5; Co-siRNA = 1, n = 6, p = 0.025).
A green asterisk marks the treated side. Scale bars, 50 mm. See also Figures S3A and S3B.
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the anti-apoptotic marker BCL2 were affected by the loss of
cMyc as compared to the contralateral side treated with control
morpholino. Expression values were similar to control embryos
treated with control morpholino on both sides. However, in the
same embryos, neural crest markers FoxD3 and Sox10 were
significantly decreased on the cMycMO-treated side, consistent
with loss of neural crest cells, whereas control embryos had
no phenotype. Interestingly, we also noted the upregulation of
p27—a cyclin-dependent kinase inhibitor (CDKI) associated
with cMyc activity (Yang et al., 2001)—on the cMycMO-treated
side (Figure 4G). In light of this, we analyzed the expression of
p27 in wild-type embryos. The results reveal p27 transcripts
throughout the neural tube, albeit with much reduced expression
in the premigratory and early migrating neural crest cells
(Figure S3B).
To gain mechanistic insight, we repeated these experiments in
the crestospheres. Similar to the embryo, the results show that
proliferation was unaffected in crestospheres by loss of cMyc
(Figures 4H and 4I). However, unlike the situation in the embryo,
cMyc knockdown in crestospheres did not trigger apoptosis
(Figures 4H and 4J), suggesting that the cell death in the embryo
may be a secondary consequence of loss of self-renewal ability
in vivo. Despite the rather low transfection efficiency in cresto-
spheres (30%), we also detected a significant increase in the
levels of p27 transcript expression (Figure 4K).
The qPCR results raised the possibility that, in the neural
crest, cMyc did not affect known ‘‘canonical’’ downstream
targets whereby cMyc, with its binding partner Max, activates
transcription via E-Box binding. In search of an alternative mech-
anism for the role of cMyc in cell self-renewal and survival, we
investigated the possible involvement of Miz1, a transcription
factor that works as a transcriptional repressor when bound
to cMyc/Max. Miz1/Myc targets include CDKIs (Adhikary and
Eilers, 2005). Moreover, we previously found that Miz1 is
required for proper induction of neural crest cells at the neural
plate border (Figure 5A; Kerosuo and Bronner, 2014).
Based on the elevated levels of p27 after loss of cMyc, we hy-
pothesized that cMyc may bind to Miz1 in the premigratory neu-
ral crest to form a repressive complex. To test this possibility, we
performed co-immunoprecipitation (IP) in vivo of neural tubes at
the HH stage 8–9. The results show that an Ab to a FLAG-tagged
chickenMiz1 expressed inmoderate levels (1 mg/mL) precipitates
endogenous cMyc, demonstrating that the two transcription
factors, indeed, form a complex in the neural crest cells at the
correct stage (Figure 5B).
To examine the importance of the Miz1/cMyc interaction, we
tested the ability of either full-length cMyc (FL cMyc) or cMyc
with a single-point mutation that renders it incapable of binding
to Miz1 (V394DMyc; Herold et al., 2002) to rescue the loss of
cMyc phenotype. To this end, we simultaneously knocked
down cMyc in the premigratory neural crest cells in vivo and
added back either human FL cMyc or themutated V394D version
that is unable to bind to Miz1 (Figure 5C). Using the human
version of the protein has the additional advantage of being un-
affected by themorpholino. Moreover, there is high conservation
of the Myc-binding domains (Peukert et al., 1997) between hu-
man and chicken Miz1 proteins (Figure S3C). We used western
blots (WBs) to verify efficient expression of the human constructsin the HH stage 9 embryos after electroporation at gastrula
stages (Figure 5D). As confirmation of the specificity of the mor-
pholino, FL cMyc was able to rescue the morpholino knockdown
phenotype and restore normal levels of Sox10 expression by
qPCR and in situ hybridization (Figures 5E and 5F). In contrast,
the mutated V394DMyc, which is unable to bind toMiz1, was un-
able to rescue the cMyc loss-of-function phenotype (Figures 5E
and 5G). Furthermore, we used a Fucci construct to analyze
possible differences in the cell-cycle phases and, indeed, de-
tected more cells arrested in G1 phase on the cMyc-morphant
side, thus further supporting the involvement of Myc/Miz1 in
cell-cycle progression and self-renewal (Figures 5H and 5I).
Next, we asked whether overexpression of cMyc in the pre-
migratory/early migrating neural crest cells affects neural crest
development. We found that overexpression (2 mg/mL) of FL
cMyc caused an increase in neural crest cell production, yielding
more premigratory neural crest cells and a prolonged emigration
time (Figures 6A and 6C–6E). The cells emigrated prematurely in
60% of the embryos (Figures 6A and 6C), and, in roughly half of
them, the formation of Sox10-positive cells also continued in the
dorsal neural tube on the cMyc-overexpressing side at a time
when Sox10-positive cells were no longer observed on the con-
trol side (Figure 6D [black arrow]; Figure S3D). While this pheno-
type was predominant, aminority of embryos lacked neural crest
cells (Figure 6C), perhaps due to variability in levels of expres-
sion, as high expression levels also caused degradation and fail-
ure of neural tube closure in themajority of embryos (Figure S3E).
At lower levels (0.5 mg/mL), neural crest cells also emigrated
from the neural tube earlier than on the control side (Figure S3F),
similar to effects observed with higher levels. In contrast
to FL cMyc, embryos overexpressing the V394DMyc mutant
(2 mg/mL) had no phenotype, and only a small percentage
(11%) had neural tube closure defects (Figures 6B, 6C, and 6F;
Figures S3D and S3E). These results suggest that the ability to
bind to Miz1 is required for the effect of cMyc in premigratory
neural crest cells.
Finally, we investigated whether overexpression of either FL
cMyc or V394DMyc mutant had an impact on self-renewal, cell
proliferation, or cell survival in crestospheres. Similar to observa-
tions in the embryo, overexpression of FL cMyc clearly showed a
significant increase in self-renewal capacity with the FL cMyc,
but not the V394D Myc (Figure 6G). Neither proliferation, as as-
sayed by PH3 staining, nor cell survival were affected (Figures
6H and 6I). These results suggest that self-renewal and prolifer-
ation may be regulated via different mechanisms.
DISCUSSION
Neural crest cells are a population of multipotent cells with broad
developmental potential in vivo, exceeded only by the inner-cell-
mass cells of the blastocyst in their ability to contribute to multi-
ple cell types characteristic of ‘‘all three germ layers.’’ Under-
standing neural crest cell function is highly clinically relevant,
given the large spectrum of neural-crest-derived disorders,
including craniofacial, cardiovascular, peripheral nervous sys-
tem, and enteric syndromes. Aggressive cancers like neuroblas-
toma and melanoma also originate from this cell population
(Takahashi et al., 2013). Furthermore, due to its broad range ofCell Reports 17, 2648–2659, December 6, 2016 2653
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Figure 5. cMyc Requires Miz1 for Its Function in the Neural Crest Cells at Premigratory Stage
(A) Miz1 knockdown causes defects in neural crest formation in the dorsal neural tube similar to those seen with cMyc.
(B) Consistent with this, endogenous cMyc is detected byWB after co-IP with a FLAG-tagged chickenMiz1 protein (electroporated in low levels, 1 mg/mL) fromHH
stage 8–9 chick neural tubes by using an anti-FLAG Ab but not with control IgG (n = 3).
(C and D) In (C), the requirement forMiz1 bindingwas tested by performing a rescue experiment by using thewild-type (WT) full-length (FL cMyc) human cMyc and
a mutated form (V394Myc) unable to bind to Miz1; (D) both FL cMyc and V394DMyc are expressed at similar levels in the chick embryo after electroporation, as
verified by a WB and compared to a chick control lysate (n = 3).
(E) The FL cMyc, but not mutated V394DMyc, rescues the cMycMo phenotype assayed by qPCR by measuring expression levels of the neural crest marker
Sox10. This shows requirement for Miz1 binding for the function of cMyc in the neural crest cells at premigratory stage (average of Sox10 expression for cMycMO
alone = 0.44, SEM = 0.061, n = 6; average for cMycMo rescued with FL cMYC = 0.88, SEM = 0.156, n = 7; average for CoMo on both sides = 0.92, SEM = 0.032,
n = 7; average for cMycMO rescued with V394DMyc = 0.48, SEM = 0.988, n = 4; MycMO/MycMO + FLcMyc p = 0.0183, t test; CoMo/ MycMO p = 0.00042, t test;
CoMo/cMycMO + V394DMyc p = 0.0080, t test).
(F and G) Visualization of the rescue experiments by using in situ hybridization for Sox10 (F). The cMycMo phenotype is rescued by co-electroporation of FL cMyc
(G) but not with V394DMyc.
(H and I) The pRetroX-G1-red construct was electroporated to monitor cell cycle. An almost 3-fold increase in cells in G1 phase was seen on the cMycMO side as
compared to the control side (cMycMO, 2.9-fold, SEM = 0.30; CoMo, 1-fold, SEM = 0.12; p = 6.184E-06; n = 12 embryos) (H) visualized as more red nuclei on the
cMycMo side in a x-section from an early stage 9 embryo (I). The FITC-labeled morpholinos are shown as a control of equal electroporation on both sides of the
embryo.
A green asterisk marks the treated side. Scale bars, 20 mm. See also Figure S3C.derivatives, neural crest stem cells hold great promise for regen-
erative medicine. Multiple in vitro approaches have been used to
understand cues required for their development and stem cell
maintenance (Kerosuo et al., 2015; Lee et al., 2007, 2010). Neural
crest cells can be derived from human embryonic stem (ES)
cells or postnatal fibroblast cells in vitro; however, these do not
resemble premigratory neural crest cells within the neural tube.2654 Cell Reports 17, 2648–2659, December 6, 2016Rather, these cultures exhibit various features of late, committed
neural crest cells intermixed with multipotent cells (Kim et al.,
2014). Despite the importance of understanding these initial reg-
ulatory events, the regulation of the premigratory neural crest
stem cell pool is poorly understood. To address this question,
we have used an in vivo approach in the chick embryo combined
with in vitro premigratory crestospheres (Kerosuo et al., 2015).
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Figure 6. cMycOverexpression Increases Self-Renewal, butMiz1-BindingMutant V394DMyc Causes No Phenotype in the Neural Crest Cells
(A–C) Overexpression of FL cMyc causes premature emigration and an increased number of neural crest cells in60% (n = 25 for stages 9–11 combined) of the
embryos (A), whereas V394DMyc doesn’t induce a phenotype (B) (n = 27 for stages 9–11 combined).
(D–F) In (D), we also observed prolongation of neural crest production by the dorsal neural tube on the Myc-overexpressing side (black arrow) at HH stage 10, (E)
which results in increased numbers of neural crest cells that have migrated further laterally (white arrow) than on the control side at stage 11. (F) V394DMyc
overexpression does not induce a phenotype at a later stage either. An asterisk marks the overexpression side.
(G) Overexpression of FL cMyc, but not V394DMyc, increases self-renewal capacity in crestospheres (FL = 1.6-fold, SEM = 0.08, n = 6; V394D = 1.1, SEM = 0.05,
n = 6; control = 1, SEM = 0.05, n = 6; FL/Co-IP = 0.0002, t test; FL/V394D p = 0.0007; V394D/Co-IP = 0.17).
(H) Proliferation is not altered in crestospheres due to overexpression of either cMyc FL or V394DMyc that has lost Miz1-binding ability (analyzed by using PH3
immunostaining: FL cMyc = 0.9-fold, SEM = 0.06, n = 14 spheres; V394D = 1.25, SEM = 0.16, n = 14 spheres; control = 1, SEM = 0.26, n = 17 spheres; all ps > 0.5,
t test).
(I) Cell survival is not affected in crestospheres after overexpression of cMyc FL or the mutated V394DMyc (analyzed by using Caspase-3 immunostaining: cMyc
FL = 0.96; SEM = 0.06; n = 14 spheres; V394D = 1.29, SEM = 0.13, n = 14 spheres; control = 1, SEM = 0.08, n = 17 spheres; all ps > 0.5, t test).
Scale bars, 20 mm. See also Figures S3D–S3G.Here, we show that cMyc is involved in regulating the size of the
premigratory neural crest stem cell pool as well as the duration of
the neural crest cell emigration period. Our results, thus, provide
in vivo insight into the timing and maintenance of neural crest
production.
We show that cMyc is expressed in neural crest cells in the
dorsal neural tube at stages correlating with initiation of EMT
(Figure 1; Figure S1). This contrasts with observations in the
frog where there appears to have been a paralog switch be-
tween cMyc and nMyc compared with the chick. In Xenopus
embryos, cMyc is expressed much earlier at the neural plate
border, where it appears to play a role in neural crest induction,
but not later in maintenance of the stem cell pool (Bellmeyer
et al., 2003). In chick, we find that knockdown of cMyc using
a translation-blocking morpholino (cMycMO) results in fewer
neural crest cells and a reduction in neural crest markers,
Sox10, FoxD3, and Pax7. While the expression levels of these
markers in individual cells was unchanged (Figure 2), indicating
that neural crest induction occurred normally, the numbers ofneural crest cells appeared decreased. Importantly, cMyc
knockdown resulted in premature cessation of the neural crest
cell production by the dorsal neural tube (Figure 2), likely reflect-
ing a reduced self-renewal capacity. Conversely, we observed
prolonged neural crest production and emigration after cMyc
overexpression (Figure 6). Using a complementary in vitro
approach of crestospheres (Kerosuo et al., 2015), we noted a
reduction in the self-renewal ability of premigratory neural crest
cells due to cMyc knockdown (Figure 3). Reciprocally, self-
renewal was increased upon overexpression of cMyc (Figure 6).
This is consistent with the strong connection previously noted
between cMyc and maintenance of self-renewal in several other
types of stem cells (Chappell and Dalton, 2013; Kerosuo et al.,
2008; Murphy et al., 2005; Takahashi and Yamanaka, 2006).
Loss of cMyc seemed to affect the numbers of the multipotent
stem cells rather than affecting capacity to maintain a certain
lineage, as shown by the fact that cMyc-deficient neural crest
cells are still able to form all major types of neural crest deriva-
tives (Figure 3). Previous studies point to cMyc’s pivotal role inCell Reports 17, 2648–2659, December 6, 2016 2655
adhesion-related changes during exit from the hematopoietic
and epidermal stem cell niches (Frye et al., 2003; Varlakhanova
et al., 2010; Waikel et al., 2001; Wilson et al., 2004). Consistent
with this, the timing of cMyc expression correlates with the
onset of neural crest EMT that is accompanied by adhesion
changes in which Miz1 has been implicated (Kerosuo and Bron-
ner, 2014). Moreover, in keratinocytes, Miz1 binding is required
for these changes (Gebhardt et al., 2006), in line with the results
shown here. However, a direct link between cMyc-regulated
self-renewal and cell-adhesion changes during neural crest
EMT has yet to be established.
We detected an increase in apoptotic cells on the cMycMO-
electroporated side, resulting in a thinner dorsal neural tube.
On the other hand, cell proliferation, perhaps representing the
most commonly known function of cMyc, was not significantly
altered. Moreover, levels of known cMyc downstream targets
that promote proliferation or cell survival were unaffected
(Figure 4). Therefore, we investigated alternative mechanisms
whereby cMyc might affect target gene expression by interact-
ing with Miz1 or RAREs (Adhikary and Eilers, 2005; Uribesalgo
et al., 2012). Indeed, we detected upregulated levels of p27, a
CDKI that suggested a possible connection with Miz1. Downre-
gulation of p27 has been associated previously with cMyc, albeit
not linked toMiz1 (Yang et al., 2001; Zindy et al., 2006), and high-
lights the possibility that additional CDKIs may be involved in
maintenance of the neural crest stem cell pool. To test a possible
interaction between cMyc and Miz1, we performed rescue ex-
periments by co-electroporating cMycMO with either wild-type
or a mutated version of cMyc incapable of binding to Miz1.
Whereas the former gave efficient rescue, demonstrating the
specificity of the phenotype, the latter was unable to rescue
the cMyc-deficient phenotype (Figure 5), consistent with cMyc
binding to Miz1 and repressing its activating function. Moreover,
co-immunoprecipitation (co-IP) showed that cMyc and Miz1,
indeed, bind to one another in the chick neural tube during pre-
migratory neural crest stages. We also detected an increase of
neural crest cells in G1 cell-cycle arrest after loss of cMyc (Fig-
ure 5), which, we speculate, triggers apoptosis of these cells
as shown in Figure 4. Although a similar increase in apoptosis
was not observed in crestospheres (Figure 4), this may be due
to the relatively low transfection efficiency in vitro compared
with much higher penetration of morpholino in the embryo. In
addition to being important for maintenance of the stem cell
pool shown here, Miz1 also plays an earlier role in neural crest
specification that is independent of cMyc and occurs prior to
expression of the latter (Kerosuo and Bronner, 2014). Consistent
with these results, Miz1 is known to form repressive complexes
with transcription factors other than cMyc (Basu et al., 2009;
Phan et al., 2005). Interestingly, overexpression of the mutated
cMycV394D form that is incapable of binding to Miz1 had no
effect on neural crest development or self-renewal (Figures 5
and 6), further strengthening the hypothesis that the action of
cMyc in the premigratory neural crest cells is specific to its
interaction with Miz1.
It has been shown that heterogeneous endogenous levels of
cMyc expression are key for creating cell competition for fitness
inmouse epiblast cells, resulting in apoptotic elimination of those
cells with lowest cMyc levels (Claverı´a et al., 2013). This phe-2656 Cell Reports 17, 2648–2659, December 6, 2016nomenon is also seen in the Drosophila wing after ectopic
expression (Johnston, 2009), suggesting a widely utilized mech-
anism for stem cell niche homeostasis during development.
Similarly, we show that transient knockdown or overexpression
of cMyc via electroporation, which produces unequal levels of
cMyc in neighboring cells, alters the size of the neural crest
precursor pool. Our results implicate cMyc in regulating the
overall amount of neural crest production in the embryo. We
show that cMyc acts in the neural crest via binding to Miz1,
thus changing it from an activator to a repressor.
In summary, our results reveal a mechanism of self-renewal
regulation in the neural crest population at premigratory stages.
This involves a non-canonical function for the proto-oncoprotein
cMyc: despite the fact that cMyc plays a variety of roles in devel-
opment and cancer, its primary—and, perhaps, sole—function in
the premigratory neural crest seems to be inmaintenance of self-
renewal. This is distinct from its role at later stages, for example,
where cMyc has been show to promote neuronal differentiation
in the neural tube in vivo (Zinin et al., 2014). The neural crest is
often characterized as a transient cell population that emigrates
from the neural tube and differentiates into multiple derivatives.
Despite its ephemeral nature, our results reveal the importance
of the self-renewal capability of premigratory cells, regulated
by cMyc/Miz, in determining the size of the neural crest stem
cell pool.
EXPERIMENTAL PROCEDURES
In Situ Hybridization
Embryos were fixedwith 4%paraformaldehyde (PFA), washedwith PBS/0.1%
Tween, dehydrated in MeOH, and stored at 20C. The avian cMyc probe
was made by using cEST191o11 (http://www.chick.manchester.ac.uk), and
the Sox10, FoxD3, Dlx-5, and Sox2 probes were made by cloning respective
genes to DNA vectors from RT-PCR products made by using chicken
whole-embryo cDNA as the template. Whole-mount in situ hybridization
was performed as described previously (Acloque et al., 2008). The digoxi-
genin (dig)-conjugated RNA probes were visualized by using anti dig-AP
Ab (11093274910, Roche Diagnostics GmbH in 1/2,000) and NCB/BCIP
(11383213001 and 11383221001, Roche Diagnostics GmbH). Embryos were
sectioned at 12–18 mm.
Morpholino Knockdown and HH4 Electroporation of the Chicken
Embryos
FITC (fluorescein isothiocyanate)-conjugated morpholinos were purchased
from Gene Tools LLC (http://www.gene-tools.com). The cMyc (CTGCGA
GACGGAGCGAGGCAATAAT) and Miz-1 (AACTGGGACAGCTGCTGCAAGC
CAC) translation-blocking morpholinos were targeted to the respective 50
UTR in close proximity of the ATG, and a control morpholino was designed
to ensure lack of non-specific effects from electroporation (CTGCGATGA
AAAACACGGGAGCACA). The MOs were diluted to a 1- to 2-mM concentra-
tion and electroporated together with an empty pCIG vector as carrier DNA
(1 mg/mL). The morpholino was injected as two-sided injections with control
morpholino on the contralateral side. The electroporation was carried out as
previously described (Sauka-Spengler and Barembaum, 2008). Briefly, the
chicken embryos were collected onWhatman filter papers and electroporated
at HH stage 4 by using 5.3 V and five pulses (50 mA/100 mA) and were incu-
bated on individual Petri dishes (Falcon 1008, 353 10mm) in thin albumin until
they reached the desired stage.
qPCR
mRNAwas isolated from stage 8–9 embryos by using the Ambion RNAqueous-
MicroKit to individually collect neural tubehalves fromthecMycMO-treatedand
the contralateral control morpholino (CoMo)-treated sides, respectively. The
control embryos were treated with CoMo on both sides. The results are shown
as the relative expression fold of the treated side versus the control side, or
treated crestospheres versus respective controls, and were analyzed using
the DDCT method (Livak and Schmittgen, 2001). Results from three to eight in-
dividual embryos were pooled and are shown as average values. The error bars
represent the SEM. Primers were designed to target an exon-exon boundary,
and their amplification rate was verified as linear within the margin of a ±10%
amplification rate change between points in the logarithmically diluted cDNA
standard curve. The following primers were used: Sox10fwd AGCCAGCAATT
GAGAAGAAGG; Sox10rev GAGGTGCGAAGAGTTGTCC; FoxD3fwd TCTGCG
AGTTCATCAGCAAC; FoxD3rev TTCACGAAGCAGTCGTTGAG; cMycfwd GC
AGCGACTCGGAAGAAGAACAAGAA cMycrev TGCTGGATTCAGACTCGTTC
GCTT; BCL2Fwd CGGCAACAGTATGAGGCCTTTGTT BCL2rev ATAAGCGC
CAAGAGTGATGCAAGC and P27fwd AGCCCGAGACGACATCAAACGTAA;
P27rev TTTATATCTTCCTGGCTTCACCGCCC with GaphdHfwd1 ATCACTAT
CTTCCAGGAGCGTG; GapdHrev1 AGCACCACCCTTCAGATGAG; as well as
CyclinEfwd TACCGTGCCTGTTTGTCTCTGGAA and CyclinErev AGAGGCTT
TGAAATGTCGCCTTGC with GapdHfwd2 CAGAGGACCAGGTTGTCTCC and
GapdHrev2 CAGGGTTGCTGTATCCAAAC.
Immunostaining, WB, and IP
The following primary antibodies were used for immunofluorescence:
caspase-3 (1/200, R&D Systems, AF835) and Pax7 (1/10; Developmental
Studies Hybridoma Bank, University of Iowa), Sox2 (1/1000 Abcam 9795),
Mitf (1/500, Abcam ab122982), Tuj-1 (1/400, Covance MMS-435P), SMA
(1/1,000, Sigma A5228), BLBP (1/200, Millipore ABN14), Cherry (1/150, Clon-
tech Living colors 632543), and Histone H3 phospho S10 (1/2,000, Abcam
14955). Antibodies were incubated in PBS /0.2% Tween, 1% DMSO, and
10% goat serum with whole-mount embryos for 2 days in 4C or, alterna-
tively, on 12-mm cryosections overnight, and by using the respective second-
ary antibodies by Alexa Fluor (1/1,000; http://www.bdbiosciences.com). The
cells were imaged using fluorescence microscopy (Zeiss Axioscope 2 and
Zeiss ApoTome.2).
For western blot, SDS-PAGE was performed by using 4%–12% or 8% Bolt
and Bis-Tris Plus gels (NW04120Box and NW0080Box, Invitrogen) with the
Novex electrophoresis chamber system (Life Technologies) followed by a
transfer onto the nitrocellulose filter by using the Bio-Rad Criterion blotter.
The filters were blocked with 4% milk/PBS-0.2% Tween for 1 hr at RT and
stained with primary Ab overnight at 4C, washed 53 with PBS-0.2% Tween
at RT, incubated with the secondary Ab in block for 1.5 hr at RT, washed
53, and illuminated by using ECL (Amersham, RPN2232). The following
primary antibodies were used for WB: FLAG (1/4,000, M2 F1804, Sigma),
cMyc (c-8, 1/50, Santa Cruz Biotechnology SC-41), cMyc (N262, 1/3,000,
Santa Cruz, SC-764), b-Tubulin (1/10,000, Sigma T5168), and ribosomal S6
(1/5,000, Cell Signaling 5G10). The following secondary antibodies were
used for WB: peroxidase-labeled Gt anti-Rb IgG (immunoglobulin G) (KPL
074-1806, 1/20,000), Gt anti-Ms IgG (KPL074-1506; 1/20,000). For IP, pre-
swollen protein G-agarose beads (Sigma P7700) were coated with 20 mg of
FLAG Ab (M2 F1804 Sigma) or Ms IgG1 (Santa Cruz SC-3877) overnight at
4C, washed, and added onto lysed stage 8–9 (five- to seven-somite) chick
embryo neural tubes (from anterior tip up to somite-2 level in 900 mL lysis buffer
consisting of 50mMTris-HCL [pH 7.4], 150mMNaCl, 1%NP-40 with protease
inhibitor cocktail [cOmplete, EDTA-free, Roche 11873580001]) and incubated
at RT for 3 hr. The beads were then washed 63 with lysis buffer, and beads
were detached by using 50 mL 8 M urea/2.5% SDS (for 30 min at 65C), and
the supernatant was run on an SDS-PAGE gel as described earlier and blotted
with the anti-Myc ab.
Cell Survival and Proliferation
Cell survival and proliferation were measured by counting the percentage of
caspase-3 and PH3 immunopositive cells on cryosections or z stack images
on whole crestospheres, respectively, from all DAPI-stained nuclei in the dor-
sal neural tube at the premigratory neural crest stage. The cMycMo-electropo-
rated side was compared to the CoMo side. The results from 10–20 sections
from each embryo were pooled to represent each embryo (n). For the cresto-
sphere experiments, two to four z stack slices per sphere (at least 5 mm apart
from each other) were counted.Expression Constructs
Thecodingsequencesof thehuman cMycand themutated cMycV394D (Herold
et al., 2002), a kind gift fromMartin Eilers, were subcloned, and the chickenMiz1
gene was cloned into the pCI-RFP (red fluorescent protein) chicken expression
vector. For Miz-1, the 50 end was tagged with a 13 FLAG sequence that was
inserted into the PCR primers, and chicken cDNA was used as a template
(Miz1gallusFwd with FLAG/Bstb1 TTTTTCGAAGCCACCATGGACTACAAG
GACGACGACGACAAGGCAGCAatggatttcccccagcacag, Miz1gallusRev with
NheI TTTT GCTAGC ttttacaccgtttccaagca). The G1 cell-cycle arrest was moni-
tored by the expression of pRetroX-G1-red (Clontech 631463) by electropora-
tion (1 mg/mL) together with either cMycMO or CoMO, respectively, the expres-
sion was enhanced by using an anti-Cherry Ab, and the percentage of positive
cells was measured as compared to DAPI staining on sections as described
earlier.
Self-Renewal Assay, siRNA Transfection, and DNA Transfection into
Crestospheres
Self-renewal was measured in crestospheres by counting the ability of single
cells to form new spheres after a week in crestosphere stem cell culture, as
described in Figure 3A (Kerosuo et al., 2015). Accumax (Innovative Cell Tech-
nologies) was used (15 min at RT accompanied with trituration with a p1000
pipette) to dissociate the crestospheres into single cells. The custom-de-
signed siRNA for avian cMyc (Ambion, designed to target the following se-
quences: #1, GCAUCAGAGGAGCACUGUA; and #2, GCAGGGUCCUCAAA
CAGAU) and the control (Silencer Select Negative Control #1, Ambion
4390843) were transfected by using the HiPerfect kit (QIAGEN 301704) or
the Lipofectamine 3000 kit (Invitrogen L3000008), respectively, and by using
750 ng siRNA/200,000 cells incubated for 3 days before performing the col-
ony-forming self-renewal assay. DNA was transfected according to instruc-
tions by using the Lipofectamine 3000 kit (Invitrogen L3000008) with 1.5 mL
Lipofectamine and 500 ng of DNA per each 24-well plate well, and the self-
renewal assay was performed on day 3 after the transfection.
Explant Cultures
Embryos were electroporated at the gastrula (HH4) stage with either cMycMO
or CoMo on one side of the embryo and grown on filter papers until they
reached premigratory (the four- to five-somite) stage. Halves of cranial neural
tubes were dissected out and placed on fibronectin-coated (5 mg/mL in PBS
for 2 hr at room temperature [RT]) coverglasses and cultured in DMEM with
1% FBS for 1 week (for SMA and melanocyte differentiation); or, alternatively,
laminin-coated (50 mg/mL for 30 min at 37C), coverglasses with DMEM com-
plemented with N2 supplement (for neural and glial differentiation), fixed for
20 min in 4% PFA at RT, and immunostained.
Statistical Methods
All averages represent the data pooled from at least three biological samples
(n), either individual embryos or individually prepared batches of cresto-
spheres. Error bars represent the SEM, and the p values were calculated by
using Student’s t test; *p < 0.05, **p < 0.01.
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